chuminhua2019-10-23 23:33
10/22,Trovagene公$Trovagene(TROV)$ 宣布,其在研PLK1抑制剂onvansertib(PCM-075),与Folfiri,Avastin(bevacizumab)联合,作为二线疗法在治疗携带KRAS基因突变的转移性结直肠癌(CRC)患者的1b/2期临床试验中,取得积极的试验初期数据。在第一批患者的分析中,观察到肿瘤KRAS基因突变负荷水...查看全文
牛唐2019-08-21 14:21
$Ardelyx(ARDX)$ $Trovagene(TROV)$ 放量上涨的runup走势,9月13号,ARDX的药物Ibresla在IBS适应症方面会有审批,9月底前计划公布高磷酸盐血症方面的三期topline data;trov是在8月24日计划公布 Onvansertib 与Zytiga的二期数据$复星医药(SH600196)$查看全文
越炒股越美2019-04-25 14:53
【汇众医疗】4月23日医药股盘点:6支生物制药股势头强劲,上涨幅度均高于15%
$Atossa Genetics(ATOS)$$Trovagene(TROV)$ $Athersys(ATHX)$ 4月23日股市收盘时,6支生物制药公司股票上涨,涨幅均高于15%。而研发乳腺癌药物的Atossa Genetics以3.48美元收盘,上涨22.97%,涨幅最大。研究罕见病药...查看全文
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-06-27 AccNo: 0001193125-18-205087 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-06-22 AccNo: 0001193125-18-201229 Size: 46 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financi...
$TrovaGene, Inc.(TROV)$ 内部交易: 2018-06-20,Director,Markin Rodney S ,买入,41200普通股, $0.85
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-06-21 AccNo: 0001193125-18-198992 Size: 31 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-06-18 AccNo: 0000921895-18-001943 Size: 142 KB 网页链接
$TrovaGene, Inc.(TROV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-06-18 AccNo: 0000921895-18-001943 Size: 142 KB 网页链接
$TrovaGene, Inc.(TROV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-06-15 AccNo: 0001144204-18-034444 Size: 64 KB 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-06-15 AccNo: 0001193125-18-193972 Size: 47 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-06-12 AccNo: 0001193125-18-190679 Size: 230 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 内部交易: 2018-06-08,Director,Tennant Stanley ,买入,10000普通股, $0.80